Concepedia

Author

Dietrich W. Beelen

Essen University HospitalORCID

Also Known As

Arnold Ganser, Axel Hinke, B Dietrich, B. Dietrich, Beelen D., Beelen Dietrich, Beelen Dietrich W., Beelen, D., Beelen, Dietrich, Beelen, Dietrich W

669

Publications

18.7K

Citations

69

H-Index

153

Concepts

All Affiliations

Essen University HospitalUniversität HamburgUniversity Medical Center Hamburg-EppendorfHôpital Saint-LouisSheba Medical Center
DW

About

Dietrich W. Beelen is an author at Essen University Hospital specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

41

112

6.1K

2

Health Sciences

26

44

2K

3

Public Health

3

3

106

4

Engineering

1

1

11

5

Management

1

1

11

Dietrich W. Beelen

×

249

Publications

15.3K

Citations

67

H-Index

YearCitations

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke,

Leukemia

2015

535

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

Cristina Toffalori, Laura Zito, Valentina Gambacorta,

Nature Medicine

2019

393

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Ahmet Elmaağaclı, Nina K. Steckel, Michael Koldehoff,

Blood

2011

310

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

Peter Dreger, Hartmut Döhner, Matthias Ritgen,

Blood

2010

302

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

ZiYi Lim, Ronald Brand, Rodrigo Martino,

Journal of Clinical Oncology

2009

300

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun,

Nature Medicine

2018

283

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

Martin Bornhäuser, Joachim Kienast, Rudolf Trenschel,

The Lancet Oncology

2012

269

Influence of Intestinal Bacterial Decontamination Using Metronidazole and Ciprofloxacin or Ciprofloxacin Alone on the Development of Acute Graft-Versus-Host Disease After Marrow Transplantation in Patients With Hematologic Malignancies: Final Results and Long-Term Follow-Up of an Open-Label Prospective Randomized Trial

Dietrich W. Beelen, Ahmet Elmaağaclı, Karl‐Dieter Müller,

Blood

1999

267

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia

Wolfgang Bethge, Jolanta Dengler, M Bornhäuser,

Leukemia

2012

228

CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT

Martin Schmidt‐Hieber, Myriam Labopin, Dietrich W. Beelen,

Blood

2013

223

Page 1